Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Nxera Pharma to receive $8.6M milestone payment from Centessa Pharmaceuticals (now owned by Eli Lilly) for progress in OX2R agonist pipeline development.
BearingPoint integrates its GenAIQ AI platform with DocuSign Intelligent Agreement Management (IAM) to help procurement teams recover hidden contract value.
ONWARD Medical has initiated the EIGER clinical feasibility study to evaluate the ARC-IM System for restoring mobility in individuals with subacute or chronic spinal cord injury (SCI).
